TXG News and Press, 10x Genomics Inc. From 07/17/25

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery PR Newswire Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases ...

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 PR Newswire PLEASANTON, Calif. , July 10, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial res...

2025-07-08 11:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-06-25 18:12:53 ET More on Thermo Fisher Scientific, Illumina Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued? Thermo Fisher Is Strengthening Its Long-Term Advantage Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic ...

2025-06-23 13:47:36 ET Today, I am putting life sciences company 10x Genomics, Inc.. ( TXG ) in the spotlight for the first time. TXG stock is down 45% over the past 12 months but has been moving up over the past couple of months. The company posted better than expected firs...

2025-06-05 02:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-05-23 07:41:36 ET Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and according to data compiled by S&P Global Market Intelligence ...

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker PR Newswire PLEASANTON, Calif. , May 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a s...

2025-05-14 07:51:11 ET More on Bruker, 10x Genomics 10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript Bruker Corporation 2025 Q1 - Results - Earnings Call Presentation Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript 10x Genomics GAAP EPS of...

2025-05-08 21:34:00 ET 10x Genomics, Inc. (TXG) Q1 2025 Earnings Conference Call May 08, 2025 4:30 PM ET Company Participants Cassie Corneau – Senior Director, Investor Relations Serge Saxonov – Chief Executive Officer and Co-Founder Adam Taich ...